ConductScience.org, home

Paper3199067

Resistance of cytolytic lymphocytes to perforin-mediated killing. Lack of correlation with complement-associated homologous species restriction.

Jiang SB and 5 others. J Exp Med, 1988. Cited by 52 papers, by iCite.

Cite this record

ConductScience Library. Resistance of cytolytic lymphocytes to perforin-mediated killing. Lack of correlation with complement-associated homologous species restriction. Papers, record 3199067. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3199067

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Resistance of cytolytic lymphocytes to perforin-mediated killing. Lack of correlation with complement-associated homologous species restriction.
PubMed
Journal
J Exp Med
PubMed
Year
1988
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
52
iCite
Relative citation ratio, by iCite
1.27
iCite
Revised in PubMed
2019-05-08
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Jiang SBS B
2Persechini PMP M
3Zychlinsky AA
4Liu CCC C
5Perussia BB
6Young JDJ D

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Complement System ProteinsMajor topic
LymphocytesMajor topic
Membrane GlycoproteinsMajor topic
Membrane ProteinsMajor topic
Animals
Cell Line
Erythrocytes
Hemolysis
Killer Cells, Natural
Mice
Perforin
Pore Forming Cytotoxic Proteins
Rats
Species Specificity

Source PubMed

Download CSV of topics

Grants3

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
AI-24775NIAID NIH HHSUnited StatesP01AI024775PubMed and NIHNIH RePORTER
CA-37155NCI NIH HHSUnited StatesR01CA037155PubMed and NIHNIH RePORTER
CA-47307NCI NIH HHSUnited StatesR01CA047307PubMed and NIHNIH RePORTER

Download CSV of grants

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
14112916Immunoglobulin and theta-bearing murine leukemias and lymphomas.J Immunol1972https://conductscience.org/library/papers/4112916PubMed
23292398The molecular basis of target cell killing by human lymphocytes and of killer cell self-protection.Immunol Rev1988https://conductscience.org/library/papers/3292398PubMed
3894048Lytic activity of C5-9 complexes for erythrocytes from the species other than sheep: C9 rather than C8-dependent variation in lytic activity.J Immunol1977https://conductscience.org/library/papers/894048PubMed
46946459Homologous species restriction in lysis of erythrocytes by terminal complement proteins.Proc Natl Acad Sci U S A1981https://conductscience.org/library/papers/6946459PubMed
56833758Human natural killer cells analyzed by B73.1, a monoclonal antibody blocking Fc receptor functions. I. Characterization of the lymphocyte subset reactive with B73.1.J Immunol1983https://conductscience.org/library/papers/6833758PubMed
66347868Cytotoxic T-lymphocytes. How do they function?Immunol Rev1983https://conductscience.org/library/papers/6347868PubMed
76201674Human natural killer cells: biologic and pathologic aspects.Lab Invest1984https://conductscience.org/library/papers/6201674PubMed
86430999Evidence for restriction of the ability of complement to lyse homologous erythrocytes.J Immunol1984https://conductscience.org/library/papers/6430999PubMed
96470486Species-restricted target cell lysis by human complement: complement-lysed erythrocytes from heterologous and homologous species differ in their ratio of bound to inserted C9.J Immunol1984https://conductscience.org/library/papers/6470486PubMed
106399848Heterogeneity of natural killer cells.Annu Rev Immunol1984https://conductscience.org/library/papers/6399848PubMed
113904772Mechanism of lymphocyte-mediated cytotoxicity.Annu Rev Immunol1985https://conductscience.org/library/papers/3904772PubMed
122417226Isolation and biochemical and functional characterization of perforin 1 from cytolytic T-cell granules.Proc Natl Acad Sci U S A1985https://conductscience.org/library/papers/2417226PubMed
133512410Cell-mediated cytotoxic reactions.Hum Pathol1986https://conductscience.org/library/papers/3512410PubMed
142419413Homologous species restriction in lysis of human erythrocytes: a membrane-derived protein with C8-binding capacity functions as an inhibitor.J Immunol1986https://conductscience.org/library/papers/2419413PubMed
152419414Membrane factors responsible for homologous species restriction of complement-mediated lysis: evidence for a factor other than DAF operating at the stage of C8 and C9.J Immunol1986https://conductscience.org/library/papers/2419414PubMed
162420467Purification and characterization of a cytolytic pore-forming protein from granules of cloned lymphocytes with natural killer activity.Cell1986https://conductscience.org/library/papers/2420467PubMed
172425429The ninth component of complement and the pore-forming protein (perforin 1) from cytotoxic T cells: structural, immunological, and functional similarities.Science1986https://conductscience.org/library/papers/2425429PubMed
182427956Structural/functional similarity between proteins involved in complement- and cytotoxic T-lymphocyte-mediated cytolysis.Nature1986https://conductscience.org/library/papers/2427956PubMed
192428045Isolation of a human erythrocyte membrane protein capable of inhibiting expression of homologous complement transmembrane channels.Proc Natl Acad Sci U S A1986https://conductscience.org/library/papers/2428045PubMed
203097239Identification and characterization of a pore-forming protein of human peripheral blood natural killer cells.J Exp Med1986https://conductscience.org/library/papers/3097239PubMed

See all 39 referencesDownload CSV of references

Cited by14

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 52 citations.

PMIDTitleJournalYearIn PapersSource
27864216Resistance to anticancer immunity in cancer patients: potential strategies to reverse resistance.Ann Oncol2017https://conductscience.org/library/papers/27864216PubMed
8642292Inactivation of human immunodeficiency virus (HIV)-1 envelope-specific CD8+ cytotoxic T lymphocytes by free antigenic peptide: a self-veto mechanism?J Exp Med1996https://conductscience.org/library/papers/8642292PubMed
7835917Comparative susceptibility of peripheral blood leucocytes and related cell lines to killing by T-cell perforin.Immunology1994https://conductscience.org/library/papers/7835917PubMed
7507156Membrane defence against complement lysis: the structure and biological properties of CD59.Immunol Res1993https://conductscience.org/library/papers/7507156PubMed
2794864Purified perforin induces target cell lysis but not DNA fragmentation.J Exp Med1989https://conductscience.org/library/papers/2794864PubMed
2786549Resistance of cytolytic lymphocytes to perforin-mediated killing. Induction of resistance correlates with increase in cytotoxicity.J Exp Med1989https://conductscience.org/library/papers/2786549PubMed
2683611Biology of natural killer cells.Adv Immunol1989https://conductscience.org/library/papers/2683611PubMed
2592021Molecular cloning and chromosomal assignment of a human perforin (PFP) gene.Immunogenetics1989https://conductscience.org/library/papers/2592021PubMed
1972178Specific killing of cytotoxic T cells and antigen-presenting cells by CD4+ cytotoxic T cell clones. A novel potentially immunoregulatory T-T cell interaction in man.J Exp Med1990https://conductscience.org/library/papers/1972178PubMed
1836013Enhancement of human immunodeficiency virus type 1 infection by antisera to peptides from the envelope glycoproteins gp120/gp41.J Exp Med1991https://conductscience.org/library/papers/1836013PubMed
1741748Killing of cells by perforin. Resistance to killing is not due to diminished binding of perforin to the cell membrane.Biochem J1991https://conductscience.org/library/papers/1741748PubMed
1705281T cell-T cell killing is induced by specific epitopes: evidence for an apoptotic mechanism.J Exp Med1991https://conductscience.org/library/papers/1705281PubMed
1694224Human protectin (CD59), an 18-20-kD homologous complement restriction factor, does not restrict perforin-mediated lysis.J Exp Med1990https://conductscience.org/library/papers/1694224PubMed
1693622Membrane channel formation by the lymphocyte pore-forming protein: comparison between susceptible and resistant target cells.J Cell Biol1990https://conductscience.org/library/papers/1693622PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3199067

GET https://conductscience.org/api/papers/v1/3199067/references?page=2